CombiMatrix Falls Short of Nasdaq Listing Rule Related to Stockholders' Equity | GenomeWeb

NEW YORK (GenomeWeb News) – Nasdaq issued a warning to CombiMatrix on Monday telling the company it is not in compliance with a listing requirement calling for a minimum $2.5 million in stockholders' equity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.